Tests that detect abnormal cancer genes (DNA) circulating freely in the blood to identify nearly 50 types of cancer early are ...
The growing sophistication of tumor molecular profiling has helped to slowly transition oncologic care toward a more personalized approach in different tumor types, including in bladder cancer. The ...
A comprehensive review shows circulating tumour DNA offers powerful prognostic insight across all major mCRPC treatments, but ...
A meta-analysis of 41 studies and 3,058 patients shows that detectable circulating tumor DNA after neoadjuvant therapy ...
Serum tumor markers (STMs), including alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG), are currently used in management of patients with germ cell tumors (GCTs). STMs in a substantial ...
CHARLOTTE, N.C. — Circulating tumor DNA (ctDNA) from patients with gastrointestinal (GI) cancers can reflect treatment response, spare some additional treatment, or signal potential remission in those ...
This tutorial provides a step-by-step overview of the workflow for isolating cell-free circulating DNA from plasma or serum using the Plasma/Serum Cell-Free Circulating DNA Purification Mini Kit.
Source: Getty Images A growing body of research seeks to validate ctDNA as a means of guiding MIBC treatment, particularly immunotherapy. [Editor’s note: This article was updated in June 2026 from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results